Cargando…
Transcriptomic biomarkers for predicting response to neoadjuvant treatment in oesophageal cancer
Oesophageal cancer is a devastating disease with poor outcomes and is the sixth leading cause of cancer death worldwide. In the setting of resectable disease, there is clear evidence that neoadjuvant chemotherapy and chemoradiotherapy result in improved survival. Disappointingly, only 15%–30% of pat...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793050/ https://www.ncbi.nlm.nih.gov/pubmed/33442473 http://dx.doi.org/10.1093/gastro/goaa065 |